Opportunity Information: Apply for CDC RFA EH13 1303
Apply for CDC RFA EH13 1303
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Program to Support New Implementation of State or Territorial Public Health Laboratory Capacity for Newborn Bloodspot Screening of Severe Combined Immunodeficiency (SCID)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.065 Laboratory Leadership, Workforce Training and Management Development, Improving Public Health Laboratory Infrastructure.
- This funding opportunity was created on Mar 28, 2013 and posted on Mar 28, 2013.
- Applicants must submit their applications by May 28, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $1,800,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $400,000.00 in funding.
- The number of recipients for this funding is limited to 3 candidate(s).
- Eligible applicants include: State governments Special district governments.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This grant opportunity, titled "Program to Support New Implementation of State or Territorial Public Health Laboratory Capacity for Newborn Bloodspot Screening of Severe Combined Immunodeficiency (SCID)," was a Centers for Disease Control and Prevention (CDC) cooperative agreement intended to help more U.S. states and territories launch active newborn screening programs for SCID. The central public health goal was straightforward: increase the number of jurisdictions that routinely screen newborn bloodspot specimens for SCID so affected infants can be identified as early as possible and quickly referred for confirmatory testing and treatment. Because SCID is a life-threatening immune disorder that can be dramatically improved with timely medical intervention, the program focus was on practical implementation and laboratory readiness, not just planning.
The opportunity was issued as a discretionary funding announcement under Funding Opportunity Number CDC RFA EH13-1303, categorized within health and associated with CFDA 93.065, which covers laboratory leadership, workforce training and management development, and improvements to public health laboratory infrastructure. The use of a cooperative agreement, rather than a standard grant, signaled that CDC expected to have substantial programmatic involvement during the project period, typically through technical assistance, guidance on implementation approaches, and coordination around performance expectations. In other words, awardees would not simply receive funds and operate independently; they would work in a more hands-on partnership model with CDC to achieve screening implementation milestones.
Eligibility was limited to governmental applicants, specifically state governments and special district governments, reflecting the fact that newborn screening is generally a state- or territory-run public health function. The announcement anticipated making three awards in total, with an estimated total funding amount of $1,800,000. The stated award ceiling was $400,000, and there was no cost sharing or matching requirement, which reduces financial barriers for jurisdictions that may be ready to implement SCID screening but lack upfront resources. The award floor was listed as $0, a common administrative notation indicating that CDC did not guarantee a minimum level of funding per award beyond what would ultimately be negotiated and made available.
In practical terms, the program was aimed at building or expanding the capacity of public health laboratories to perform SCID screening on newborn dried bloodspot specimens. That typically implies helping jurisdictions put the necessary laboratory components in place, such as validated testing methods, staff training, quality assurance practices, workflow integration with existing newborn screening panels, and the operational linkages needed to ensure that abnormal results lead to rapid follow-up and clinical referral. The overarching intended outcome was to move jurisdictions from not screening for SCID to actively screening, thereby increasing the number of newborns screened nationwide and reducing the time to diagnosis for infants with SCID.
Key dates show that the opportunity was posted and created on March 28, 2013, with an original and final closing date of May 28, 2013, and an archive date of June 27, 2013. The listing noted that the additional information link in the summary page was not active and directed applicants to access the full announcement through the main posting interface. For support with accessing the full announcement, the CDC Procurement and Grants Office Technical Information Management Section (TIMS) was identified as the point of contact, with phone number 770-488-2700 and email pgotim@cdc.gov.
Frequently Asked Questions (FAQs)
What is the title of this grant opportunity?
The opportunity is titled "Program to Support New Implementation of State or Territorial Public Health Laboratory Capacity for Newborn Bloodspot Screening of Severe Combined Immunodeficiency (SCID)."
Which federal agency offered this opportunity?
This was offered by the Centers for Disease Control and Prevention (CDC).
What type of funding mechanism is this?
This opportunity used a cooperative agreement, meaning CDC expected substantial programmatic involvement during the project period (for example, providing technical assistance, guidance on implementation, and coordination around performance expectations).
What is the Funding Opportunity Number (FOA)?
The Funding Opportunity Number is CDC RFA EH13-1303.
What is the CFDA number associated with this opportunity?
The CFDA number listed is 93.065.
What was the main purpose of this cooperative agreement?
The purpose was to help more U.S. states and territories launch active newborn screening programs for SCID by increasing the number of jurisdictions that routinely screen newborn bloodspot specimens for SCID, so affected infants can be identified early and quickly referred for confirmatory testing and treatment.
What public health problem was this opportunity trying to address?
It focused on Severe Combined Immunodeficiency (SCID), a life-threatening immune disorder where outcomes can be dramatically improved with timely medical intervention. The program aimed to shorten time to identification and referral by implementing routine newborn bloodspot screening.
Was the focus on planning or on implementation?
The focus was on practical implementation and laboratory readiness, not just planning.
Who was eligible to apply?
Eligibility was limited to governmental applicants, specifically state governments and special district governments.
Why were governmental applicants the target audience for eligibility?
The announcement reflected that newborn screening is generally a state- or territory-run public health function.
How many awards were anticipated?
The announcement anticipated making three awards in total.
What was the estimated total funding amount?
The estimated total funding amount was $1,800,000.
What was the maximum (ceiling) award amount?
The stated award ceiling was $400,000.
Was there a minimum (floor) award amount?
The award floor was listed as $0. This is a common administrative notation indicating that CDC did not guarantee a minimum funding level per award beyond what would ultimately be negotiated and made available.
Was cost sharing or matching required?
No. The opportunity stated there was no cost sharing or matching requirement.
What kinds of activities was the program intended to support?
It was aimed at building or expanding public health laboratory capacity to perform SCID screening on newborn dried bloodspot specimens. This typically implies putting key laboratory components in place, such as validated testing methods, staff training, quality assurance practices, workflow integration with existing newborn screening panels, and operational linkages to ensure abnormal results lead to rapid follow-up and clinical referral.
What outcomes was CDC trying to achieve through this program?
The intended outcome was to move jurisdictions from not screening for SCID to actively screening, increasing the number of newborns screened nationwide and reducing the time to diagnosis for infants with SCID.
When was the opportunity posted?
The opportunity was posted (and created) on March 28, 2013.
What was the application deadline?
The original and final closing date was May 28, 2013.
When was the opportunity archived?
The archive date was June 27, 2013.
Where were applicants supposed to find the full announcement?
The listing noted that the "additional information" link in the summary page was not active and directed applicants to access the full announcement through the main posting interface.
Who could applicants contact for help accessing the full announcement?
Applicants were directed to the CDC Procurement and Grants Office Technical Information Management Section (TIMS).
What are the contact details for CDC TIMS?
Phone: 770-488-2700
Email: pgotim@cdc.gov
How was this opportunity categorized?
It was categorized within health and associated with CFDA 93.065, which covers laboratory leadership, workforce training and management development, and improvements to public health laboratory infrastructure.
What does it mean that this was a discretionary funding announcement?
The opportunity was described as a discretionary funding announcement (as opposed to an entitlement program). In this listing, it was issued under the FOA CDC RFA EH13-1303.
What does CDC's "substantial involvement" typically look like under a cooperative agreement?
Based on the description provided, CDC's involvement would typically include technical assistance, guidance on implementation approaches, and coordination around performance expectations, with awardees working in a hands-on partnership model with CDC to meet screening implementation milestones.
Browse more opportunities from the same category: Health
Next opportunity: Region 7 Wildlife Restoration Grant Program State Government Agencies Only
Previous opportunity: Request for Information for El Salvador Investment Challenge (ESIC)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA EH13 1303
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA EH13 1303) also looked into and applied for these:
| Funding Opportunity |
|---|
| Strategic Prevention Framework Partnerships for Success (SPF PFS) Apply for SP 13 004 Funding Number: SP 13 004 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $2,260,000 |
| Secondary Analyses of Existing Data Sets and Stored Biospecimens to Address Clinical Aging Research Questions (R01) Apply for PA 13 168 Funding Number: PA 13 168 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Genomic Medicine Pilot Demonstration Projects (U01) Apply for RFA HG 13 004 Funding Number: RFA HG 13 004 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Improving HIV Prevention and Treatment Outcomes Among HIV Infected Persons by Integrating Community Pharmacists and Clinical Sites into a Model of Patient centered HIV Care Apply for CDC RFA PS13 1315 Funding Number: CDC RFA PS13 1315 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,300,000 |
| Medical Professionals Recruitment and Continuing Education Programs Apply for HHS 2013 IHS HPR 0001 Funding Number: HHS 2013 IHS HPR 0001 Agency: Indian Health Service Category: Health Funding Amount: $25,000 |
| NIDCR Small Research Grants for Secondary Analysis of FaceBase Data (R03) Apply for PAR 13 178 Funding Number: PAR 13 178 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Undiagnosed Diseases Gene Function Research (R21) Apply for RFA RM 13 003 Funding Number: RFA RM 13 003 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Implementation Science for Strengthening Use of Evidence in Family Planning/Reproductive Health Programming (ISSUE FP/RH) Apply for SOL OAA 13 000005 Funding Number: SOL OAA 13 000005 Agency: Agency for International Development Category: Health Funding Amount: $150,000,000 |
| Child, Newborn, and Maternal Health Project Apply for RFA 391 13 000009 Funding Number: RFA 391 13 000009 Agency: Pakistan USAID Islamabad Category: Health Funding Amount: Case Dependent |
| Indo U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03) Apply for PA 13 179 Funding Number: PA 13 179 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| AHRQ Patient Centered Outcomes Research (PCOR) Mentored Research Scientist Development Award (K01) Apply for PA 13 181 Funding Number: PA 13 181 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| AHRQ Patient Centered Outcomes Research (PCOR) Mentored Clinical Investigator Award (K08) Apply for PA 13 180 Funding Number: PA 13 180 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Service Area Competition Additional Area (SAC AA) Tyler, Texas Roxbury, Massachusetts and Bristol, Florida Apply for HRSA 13 277 Funding Number: HRSA 13 277 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| FY13 Announcement of Anticipated Availability of Funds for Family Planning Services Grants (Republic of Palau) Apply for PA FPH 13 041 Funding Number: PA FPH 13 041 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $145,000 |
| State Systems Development Initiative Grant Program Apply for HRSA 13 268 Funding Number: HRSA 13 268 Agency: Health Resources and Services Administration Category: Health Funding Amount: $25,000 |
| FaceBase 2 Craniofacial Development and Dysmorphology Dataset, Tool, and Resource Development (U01) Apply for RFA DE 14 004 Funding Number: RFA DE 14 004 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| FaceBase 2 Craniofacial Development and Dysmorphology Data Management and Integration Hub (U01) Apply for RFA DE 14 005 Funding Number: RFA DE 14 005 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Occupational Safety and Health Research (R01) Apply for PAR 13 129 Funding Number: PAR 13 129 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| Family Health Plus (FH ) Project Apply for RFA 620 13 000002 Funding Number: RFA 620 13 000002 Agency: Nigeria USAID Abuja Category: Health Funding Amount: $9,000,000 |
| Advancing Alcohol Screening and Brief Intervention (aSBI) and CHOICES in American Indian and Alaska Native Populations through Training and Technical Assistance Apply for CDC RFA DD13 1301 Funding Number: CDC RFA DD13 1301 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $275,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA EH13 1303", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.